Coronary disease & ACSCohort study

Long-term impact of telemedicine for lipid control after an acute coronary syndrome

Eur J Prev CardiolPublished

  • Prospective cohort study
  • consecutive enrolment
  • single-group

Authors' conclusion

A telemedicine-based intensive lipid-lowering strategy effectively optimized LDL-c levels and was associated with reduced cardiovascular mortality in a high-risk secondary prevention cohort.

Study context

Population
Patients with acute coronary syndrome (ACS)
Participants
344 patients
Outcome
LDL-c control (LDL-c <55 mg/dL) with a telemedicine-based strategy

Main finding

As reported in the abstract

LDL-c control

Baseline LDL-c (mg/dL)

108.4±40.7

Post-intervention LDL-c (mg/dL)

48.7 ± 14.4

LDL-c <55 mg/dL achieved

82.6%

Average treatment optimization time (months)

3.2±2.1

Observational data: associations, not effects.

Further findings

Death and 4P-MACE · median follow-up 39±10 months

Died
43 (12.5%)
4P-MACE event
72 (20.9%)

Predictors of CV mortality (multivariate analysis)

LDL-c at end of follow-up, HR (95% CI 1.01-1.08), p0.024
1.04
Age, HR (95% CI 1.02-1.16), p0.004
1.09
  • independently associated

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Long-term impact of telemedicine for lipid control after an acute coronary syndrome. Eur J Prev Cardiol. Published 4 October 2025. doi:10.1093/eurjpc/zwaf630

Summarised from the published abstract; every number is checked against it